Timothée Ouassa
Timothée Ouassa publishes mostly in Infectious Diseases, Epidemiology and Surgery, on topics such as Tuberculosis Research and Epidemiology, HIV/AIDS Research and Interventions and Pneumocystis jirovecii pneumonia detection and treatment.
- World rank
- #3,971,010 of 7,710,434 ranked researchers
- Rank in Côte d'Ivoire
- #272 of 1,695
- Works
- 47
- Citations
- 1k
- Citations per work
- 22.1
What does Timothée Ouassa research?
Timothée Ouassa's work is mostly in Medicine (62%), Immunology and Microbiology (5%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2961.6%
- Medicine2961.6%
- Everything else1430.7%
- Life Sciences47.7%
- 1Infectious Diseases28% of their works
- 2Epidemiology17% of their works
- 3Surgery10% of their works
- 4Emergency Medicine6% of their works
- 5Virology5% of their works
- 6Molecular Medicine3% of their works
Research topics
- Tuberculosis Research and Epidemiology
- HIV/AIDS Research and Interventions
- Pneumocystis jirovecii pneumonia detection and treatment
- Mycobacterium research and diagnosis
- HIV Research and Treatment
- HIV-related health complications and treatments
- Diagnosis and treatment of tuberculosis
- HIV/AIDS drug development and treatment
Which keywords describe Timothée Ouassa's research?
The keywords of their largest research topics: Antiretroviral Therapy, Diagnosis, Epidemiology, Immune Response, Vaccine, Drug Resistance, HIV and Mycobacterium tuberculosis.
- Nucleoside Analogues
- Inflammation
- Cardiovascular Disease
- Abdominal Tuberculosis
- Nontuberculous Mycobacteria
- Pneumonia
- HIV Infection
- HIV Transmission
- Mycobacterium tuberculosis
- Drug Resistance
- Immune Response
- Diagnosis
- Antiretroviral Therapy
- Epidemiology
- Vaccine
- HIV
- Tuberculosis
- Preexposure Prophylaxis
- Pneumocystis
- Mycobacterium avium
- AIDS
- Antibodies
- Diagnostic Challenges
- Integrase Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Antiretroviral Therapy415 topics
- Diagnosis333 topics
- Epidemiology333 topics
- Immune Response222 topics
- Vaccine222 topics
- Drug Resistance212 topics
- HIV162 topics
- Mycobacterium tuberculosis161 topic
- Tuberculosis161 topic
- HIV Transmission141 topic
- Preexposure Prophylaxis141 topic
- HIV Infection112 topics
- Pneumocystis101 topic
- Pneumonia101 topic
- Mycobacterium avium71 topic
- Nontuberculous Mycobacteria71 topic
- AIDS61 topic
- Abdominal Tuberculosis61 topic
- Antibodies61 topic
- Cardiovascular Disease61 topic
- Diagnostic Challenges61 topic
- Inflammation61 topic
- Integrase Inhibitors51 topic
- Nucleoside Analogues51 topic
Where does Timothée Ouassa work?
Timothée Ouassa's main affiliation in the publication record is University Hospital Medical Center at Treichville, Côte d'Ivoire.
How many publications and citations does Timothée Ouassa have?
OpenAlex counts 47 works and 1,038 citations for Timothée Ouassa, an h-index of 14, ranking #3,971,010 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Timothée Ouassa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.